Director of Product Development for Cort; Tessa Kluetz Pernell, Seattle-based interior designer of TKP Design; and Kendra Nash, principal designer at Nash Design Group. They talked about the ...

NEW YORK--(BUSINESS WIRE)--Blueground, the largest global operator of furnished, flexible rentals for 30+ day stays, announces its partnership with CORT Furniture Rental - the nation’s leading ...

Corcept Therapeutics Incorporated (CORT) stock saw a modest uptick, ending the day at $42.25 which represents a slight increase of $1.33 or 3.25% from the prior close of $40.92. The stock opened at ...

Investors might want to bet on Corcept Therapeutics (CORT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

Corcept Therapeutics (CORT) shares soared 6.5% in the last trading session to close at $42.27. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Corcept Therapeutics (CORT – Research Report). The ...

Corcept (CORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Corcept, Amneal, Bioventus, Foghorn and Akebia have ...

Corcept Shares Rise More Than 45% in Six Months: Here's Why Shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) have gained 46.2% in the past six months against the industry's decline of 2%.

Investors might want to bet on Corcept Therapeutics (CORT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...